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higher-order interaction analysis in the aim of disclosing this
important issue.
During the last several years the cardiology community has been
highly influenced by medical guidelines, randomized clinical trials,
and “cost-effective” algorithms. All these tools are invaluable for
practicing medicine and in helping the decision-making process.
Nevertheless, we should not forget that a physician’s judgment is
what processes and consolidates all this information. Apparently,
in this particular clinical scenario it can still make a difference.
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Reply
Dr. Karthikeyan, in an impassioned response to the study by
Pereira et al. (1) and my accompanying editorial (2), which
highlighted the role of clinical judgment, states that detractors of
evidence-based medicine “imbue ‘clinical judgment’ with an aura,
which barely falls short of the divine.” The message in the editorial,
as well as in the original report, was not intended to either “detract”
from the appropriate role of evidence-based medicine garnered
through sound scientific research or to claim any magical powers
for clinical judgment. Rather, the main point, supported by the
findings of the study by Pereira et al. (1), is that the complexity of
the clinical decision process as well as the uniqueness of each
individual patient may not always be adequately captured in our
evidenced-based criteria.
Dr. Karthikeyan rightly points out that some of the reasons the
physicians chose one treatment over the other were objective
findings on the angiogram. Yet these physicians were better able to
risk-stratify the patients despite the a priori “equivalence” of the
findings based on the entry criteria of the trial.
No amount of clinical trial data can ever capture the almost
infinite variables involved in the complex biology of health and
disease. In addition, the somewhat arbitrary cutoffs employed in
data analysis add additional limitations. Take as an example the
findings from the SHOCK (SHould we revascularize Occluded
Coronaries for cardiogenic shocK) trial (3) that patients over the
age of 75 did not benefit from revascularization. Taken to its
absurd limit, would the thoughtful clinician withhold revascular-
ization from the robust patient who is 76 years old and, conversely,
prescribe it for the frail 74-year-old with co-morbidities?
Few would argue with the statement that evidence-based
medicine has improved clinical care. We should be careful,
however, to borrow from Dr. Karthikeyan’s own terminology, from
ascribing “divine” powers to evidence-based medicine and guide-
lines. The limitations of our knowledge base must be acknowl-
edged, as is the contribution of physician experience and judgment,
particularly in individual patients. We should also use scientific
methods, as admirably done by Pereira et al. (1), to evaluate
evidence-based medicine itself, and to help improve our clinical
decision-making process.
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